|
USP6NL expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.313600E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.392500E-02 |
| Normal-vs-Stage2 |
2.642400E-01 |
| Normal-vs-Stage3 |
7.588600E-01 |
| Normal-vs-Stage4 |
4.345400E-01 |
| Stage1-vs-Stage2 |
6.408800E-01 |
| Stage1-vs-Stage3 |
6.550300E-02 |
| Stage1-vs-Stage4 |
8.460200E-01 |
| Stage2-vs-Stage3 |
3.062000E-01 |
| Stage2-vs-Stage4 |
8.825800E-01 |
| Stage3-vs-Stage4 |
3.852400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
7.174300E-02 |
| Normal-vs-AfricanAmerican |
8.204800E-01 |
| Normal-vs-Asian |
7.877000E-01 |
| Caucasian-vs-AfricanAmerican |
3.305000E-01 |
| Caucasian-vs-Asian |
4.686400E-01 |
| AfricanAmerican-vs-Asian |
9.981200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
9.501800E-02 |
| Normal-vs-Female |
1.483010E-01 |
| Male-vs-Female |
7.575200E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.210180E-01 |
| Normal-vs-Extreme_Weight |
3.636600E-03 |
| Normal-vs-Obese |
6.326200E-01 |
| Normal-vs-Extreme_Obese |
1.881700E-02 |
| Normal_Weight-vs-Extreme_Weight |
4.379600E-01 |
| Normal_Weight-vs-Obese |
2.638600E-01 |
| Normal_Weight-vs-Extreme_Obese |
4.079200E-01 |
| Extreme_Weight-vs-Obese |
2.217800E-02 |
| Extreme_Weight-vs-Extreme_Obese |
5.989200E-01 |
| Obese-vs-Extreme_Obese |
1.120810E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.225200E-01 |
| Normal-vs-Age(41-60Yrs) |
5.898200E-01 |
| Normal-vs-Age(61-80Yrs) |
8.137200E-03 |
| Normal-vs-Age(81-100Yrs) |
5.122800E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.789800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.122700E-03 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.243000E-03 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.428050E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.344000E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.987400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
4.392400E-01 |
| Normal-VS-Type2 PRCC |
2.500100E-02 |
| Normal-VS-KIRP CIMP |
5.022000E-02 |
| Normal-VS-Unclassified PRCC |
5.850000E-01 |
| Type1 PRCC-VS-Type2 PRCC |
2.002400E-01 |
| Type1 PRCC-VS-KIRP CIMP |
6.047900E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
2.969800E-01 |
| Type2 PRCC-VS-KIRP CIMP |
9.441500E-03 |
| Type2 PRCC-VS-Unclassified PRCC |
2.905900E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
3.955200E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.355400E-03 |
| Normal-vs-N1 |
2.467200E-01 |
| Normal-vs-N2 |
9.635200E-01 |
| N0-vs-N1 |
8.793600E-02 |
| N0-vs-N2 |
3.470800E-01 |
| N1-vs-N2 |
3.121000E-01 |
|
|
